| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▼ | 1.56▲ | 1.56▲ | 1.67▼ | 1.48▲ |
| MA10 | 1.58▼ | 1.54▲ | 1.56▲ | 1.52▲ | 1.54▲ |
| MA20 | 1.56▲ | 1.56▲ | 1.64▼ | 1.42▲ | 1.29▲ |
| MA50 | 1.54▲ | 1.66▼ | 1.58▼ | 1.50▲ | 0.80▲ |
| MA100 | 1.57▲ | 1.55▲ | 1.43▲ | 1.20▲ | 1.44▲ |
| MA200 | 1.66▼ | 1.42▲ | 1.43▲ | 0.78▲ | 2.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.009▲ | -0.014▼ | 0.037▲ | 0.006▲ |
| RSI | 61.146▲ | 47.263▼ | 46.500▼ | 55.132▲ | 60.356▲ |
| STOCH | 82.407▲ | 84.563▲ | 45.110 | 81.475▲ | 38.004 |
| WILL %R | -44.444 | -16.000▲ | -65.000 | -38.272 | -48.876 |
| CCI | 43.675 | 129.611▲ | -0.878 | 41.400 | 59.919 |
|
Tuesday, December 02, 2025 04:16 AM
Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, today announced the appointment of Petra ...
|
|
Wednesday, November 12, 2025 05:10 AM
Ovid Therapeutics (OVID) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.2 per share a year ago. These figures ...
|
|
Tuesday, November 11, 2025 10:00 PM
Detailed price information for Ovid Therapeutics Inc (OVID-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/12/25 | 1.47 | 1.595 | 1.47 | 1.575 | 1,639,424 |
| 02/12/25 | 1.78 | 1.79 | 1.56 | 1.56 | 1,486,126 |
| 01/12/25 | 1.74 | 1.8199 | 1.67 | 1.80 | 3,215,875 |
| 28/11/25 | 1.665 | 1.805 | 1.5815 | 1.78 | 3,183,655 |
| 26/11/25 | 1.52 | 1.66 | 1.519 | 1.63 | 3,218,485 |
| 25/11/25 | 1.51 | 1.528 | 1.44 | 1.50 | 1,862,816 |
| 24/11/25 | 1.44 | 1.555 | 1.42 | 1.49 | 3,030,726 |
| 21/11/25 | 1.24 | 1.41 | 1.23 | 1.40 | 1,304,197 |
| 20/11/25 | 1.28 | 1.36 | 1.21 | 1.22 | 1,122,540 |
| 19/11/25 | 1.35 | 1.35 | 1.25 | 1.28 | 692,729 |
|
|
||||
|
|
||||
|
|